AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06358716 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Complete Oral Nutrition Supplement 3
Description: Liquid formula produced by several food ingredients to provide a balance nutrient intake
Study NCT06358716 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Complete Oral Nutrition Supplement 4
Description: Liquid formula produced by several food ingredients to provide a balance nutrient intake
Study NCT06358716 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Complete Oral Nutrition Supplement 5
Description: Liquid formula produced by several food ingredients to provide a balance nutrient intake
Study NCT06358716 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Complete Oral Nutrition Supplement 6
Description: Liquid formula produced by several food ingredients to provide a balance nutrient intake
Study NCT06358716 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Complete Oral Nutrition Supplement 7
Description: Liquid formula produced by several food ingredients to provide a balance nutrient intake
Study NCT05535101 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent theta burst transcranial magnetic stimulation (iTBS)
Description: The amphetamine users will undergo a one-month iTBS intervention. From Week 1 to Week 4, subjects will be treated five times a week.
Study NCT05535101 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham stimulation
Description: Sham stimulation was delivered using the same protocol as active stimulation, but with the TMS coil rotated by 90 degrees with the edge of the coil touching the scalp.
Study NCT05397743 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality of Life
Description: Questionnaire Perceived stress scale (PSS) + Questionnaire Short form 36 (SF-36) + Questionnaire Visual functioning questionnaire 25 (VFQ-25)
Study NCT05387174 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: : Nursing intervention in two risk factors of the Metabolic Syndrome, abdominal obesity and arterial hypertension and quality of life in the climacteric period.
Description: Nursing intervention with technological support (Metamorphosis) in two risk factors of Metabolic Syndrome, abdominal obesity and hypertension and quality of life in the climacteric period, developed in 3 months, in the experimental group that includes individual nursing counseling, group education virtually and physical activity sessions for 12 weeks virtually.
Study NCT05768126 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rivastigmine Transdermal Product
Description: The patches will be administered (first four weeks 4.6 mg and then 9.5. mg).
Study NCT05768126 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: The sham patches will be administered during the same period of time as the rivastigmine.
Study NCT05500716 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Auricular Non-Invazive Vagus Nerve Stimulation + Traditional Rehabilitation Program for TMD
Description: In this application, vagus nerve stimulation is applied to the patients in addition to the traditional rehabilitation program. In our research, vagal nerve stimulation will be applied with the Vagustim Device and all applications will be applied at a frequency of 10 Hz, a pulse amplitude of 300 microseconds and for 20 minutes.
Study NCT05500716 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Rehabilitation Program
Description: This intervention includes: Deep Friction Massage, Myofascial Trigger Point Compression Therapy, Temporomandibular Joint Mobilization, Rocabado Exercises, Muscle-Energy Techniques.
Study NCT05502523 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pulmonary Artery-First Surgical Technique
Description: Undergo pulmonary artery first surgical technique
Study NCT05502523 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Correlative studies
Study NCT04975074 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iron
Description: One of each type of iron was taken orally according to the instructions and followed every two weeks
Study NCT06358716 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Complete Oral Nutrition Supplement 8
Description: Liquid formula produced by several food ingredients to provide a balance nutrient intake
Study NCT06358716 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Complete Oral Nutrition Supplement 9
Description: Liquid formula produced by several food ingredients to provide a balance nutrient intake
Study NCT06358716 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Glucose
Description: 25 mg of glucose dissolved in 200 mL
Study NCT06613880 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: standard IST combined with Romiplostim N01
Description: Romiplostim N01 is a class of TPO receptor agonists. Its TPO peptide can bind to TPO receptors on megakaryocyte precursors in the bone marrow and activate them, triggering a series of intracellular signalling pathways, including JAK2/STAT5, PI3K/Akt, MEK/ERK, and p38, which ultimately lead to gene transcription and increased megakaryocyte proliferation and differentiation.
Study NCT06434337 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Novel point-of-care diagnostic test for detecting HPV (Rice HPV test)
Description: Given by Diagnostic Test
Study NCT06685198 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Titrated administration of propofol to an OAA/S score of 1 as the endpoint
Description: Propofol is titrated at a rate of 0.5 mg/kg/min to achieve an OAA/S score of 1, followed by a maintenance dose of 2-4 mg/kg/h, concurrently with remifentanil 2 ug/kg and rocuronium 0.6 mg/kg for anesthesia induction.
Study NCT06685198 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Titrated administration of propofol to an OAA/S score of 2 as the endpoint
Description: Propofol is titrated at a rate of 0.5 mg/kg/min to achieve an OAA/S score of 2, followed by a maintenance dose of 2-4 mg/kg/h, concurrently with remifentanil 2 ug/kg and rocuronium 0.6 mg/kg for anesthesia induction.
Study NCT06685198 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Titrated administration of propofol to a BIS value ≤ 60 as the endpoint
Description: Propofol is titrated at a rate of 0.5 mg/kg/min to achieve a BIS value ≤ 60, followed by a maintenance dose of 2-4 mg/kg/h, concurrently with remifentanil 2 ug/kg and rocuronium 0.6 mg/kg for anesthesia induction.
Study NCT06698003 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mogamulizumab
Description: Cohort 1: 0.3 mg/kg of mogamulizumab every 12 weeks, for 2 total doses Cohort 2: 0.3 mg/kg of mogamulizumab every 6 weeks, for 4 total doses
Study NCT06692894 — intervention group
Intervention type: OTHER
Intervention: Observational
Description: Blood will be collected from one cohort to identify potential blood biomarkers.
Study NCT06715306 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Oral treatment
Description: Patients randomized to oral treatment will commence the oral treatment immediately. The oral treatment is based on specially developed treatment suggestions developed by microbiologists and specialists in infectious diseases from the participating regions, and in respect with local treatment guidelines (detailed described in the protocol).
Study NCT06715800 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Honey
Description: Functional content analyses were performed to identify the specific properties of the different types of honey used.
Study NCT06715800 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Honey
Description: Functional content analyses were performed to identify the specific properties of the different types of honey used.
Study NCT06716073 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgery
Description: comparison of 2 surgical procedures
Study NCT06718829 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core Stability Exercises
Description: Patients will perform core stability exercises three times weekly for eight weeks. The exercises include abdominal hollowing, bridge, right-angle leg lifts with thigh press, seated twist, knee-to-chest with elbow flexion, prone abdominal hollowing, prone arm and leg lift, quadruped abdominal hollowing, quadruped arm or arm-leg lifts, and various plank positions: forearm plank, side plank, forearm plank with hip raise, and forearm plank with straight legs.
Study NCT05980286 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Piano Improvisation
Description: Piano Improvisation taught by a professional instructor for 16 weeks.
Study NCT06718829 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sensorimotor Training Exercises
Description: Patients will perform sensorimotor training exercises three times weekly for eight weeks, progressing through three phases: static (weeks 1-2), dynamic (weeks 3-4), and functional (weeks 5-8). Exercises, repeated 3-5 times per session with rest intervals, advance from simple to complex as patients master each level. Static exercises include standing on firm/soft surfaces and single-leg balances. Dynamic exercises add forward lunges and T-band kicks. Functional training incorporates walking on various surfaces, toe and heel skipping, squats, balance drills on wobble boards, and multidirectional rolling movements with visual and single-leg variations. This progression enhances coordination, balance, and functional stability.
Study NCT06718829 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional physical therapy program
Description: All patients will undergo a traditional physical therapy program consisting of stretching exercises, strengthening exercises, and scar management techniques, three times weekly for eight weeks.
Study NCT05980286 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Music Listening
Description: Music Listening facilitated by a professional instructor for 16 weeks.
Study NCT04893538 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: First analysis: Lymphocyte count > or = 1500 cells per microlitre, second analysis: IPS < 3 and third analysis: Lymphocyte/Monocyte ratio > or = 2.9
Description: Intravenous blood sampling from participants for complete blood count to obtain Lymphocyte count, Monocyte count and Lymphocyte/Monocyte Ratio and for plasma Albumin to obtain IPS
Study NCT04893538 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: First analysis: Lymphocyte count < 1500 cells per microlitre, second analysis: IPS > or = 3 and third analysis: Lymphocyte/Monocyte ratio < 2.9
Description: Intravenous blood sampling from participants for complete blood count to obtain Lymphocyte count, Monocyte count and Lymphocyte/Monocyte Ratio and for plasma Albumin to obtain IPS
Study NCT04797520 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Eko CORE Stethoscope
Description: Eko CORE stethoscope will be used as a visual and auditory means of confirming placement of ETT
Study NCT04797520 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Point of care ultrasound
Description: Point of care ultrasound will be used as a means of confirming placement of ETT. This is the gold standard used in standard of care
Study NCT05388240 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Education via a Mobile App
Description: This group will have access to Education and Resources tab that includes customary information given at a pre-op appointment plus some additional related education and resources.
Study NCT05388240 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education and Exercise via a Mobile App
Description: This group will have access to Education and Resources tab that includes customary information given at a pre-op appointment plus some additional related education and resources. The app will also be used to help guide participants through an eight-week shoulder exercise program, together with physical therapy remote support.
Study NCT04736043 — intervention group
Intervention type: OTHER
Intervention: Organoid
Description: The investigators create organoid from the pancreatic cancer tissue obtained via EUS-FNA and EUS-FNB within the pancreatic cancer diagnostic process. And also the investigators create organoid from the pancreatic cancer tissue obtained after surgery as part of the pancreatic cancer treatment process. Check for the reactivity to anti-cancer drugs through cell viability assay after treating with various anti-cancer drugs, such as anti-cancer drugs used as adjuvant chemotherapy for pancreatic cancer to the organoid. Also, perform genomic analysis on each organoid, and then check if there are any unique genomic mutations for each organoid. By recognizing the relationship between the unique genomic mutations and reactivity to the anti-cancer drug within pancreatic cancer patients eligible for surgery, the investigators aim to strategize appropriate adjuvant chemotherapy after surgery, thus developing a platform to predict the outcomes of each patient.
Study NCT06051565 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Polysaccharide superparamagnetic iron oxide injection
Description: Polysaccharide superparamagnetic iron oxide injection can be used for the treatment of iron-deficiency anemia and for magnetic resonance imaging enhancement.
Study NCT05465460 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Banana Blossom
Description: Banana Blossom 225 mg tablet orally four times per day for 14 days
Study NCT05465460 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablet orally four times per day for 14 days
Study NCT04274413 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Beta Adrenergic Sweat Test
Description: In Beta Sweat Test - sweat secretion will be stimulated by injecting a series of drugs within the skin surface. Small needles will be used to inject minute amounts of each drug. Before and after each skin injection, the skin will be cleaned using an alcohol swab.~1. Two sensor probes will be strapped to the forearm with rubber bands in position just above the injection site.~2. Under the first probe, injection atropine will be given in one small area of the skin.~3. Under the second probe, first injection carbachol will be given in one small area of the skin.~4. Next, at the second probe area, the normal sweating will be stopped for awhile by injecting a drug called atropine.~5. Lastly, beta-adrenergic sweating will be stimulated by injecting a combination of the following drugs: atropine, isoproterenol, and aminophylline (β-cocktail). Using probes, all sweat rate readings will be recorded.
Study NCT05981898 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OPTIVF dosage
Description: Dosage predicted by Opt-IVf
Study NCT05981898 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: traditional Dosage
Description: Dosage used traditionally by doctors
Study NCT05530759 — intervention group
Intervention type: PROCEDURE
Intervention: Biopsy Specimen
Description: Undergo collection of tissue samples
Study NCT05530759 — intervention group
Intervention type: PROCEDURE
Intervention: Biospecimen Collection
Description: Undergo collection of blood and buccal swab samples
Study NCT05530759 — intervention group
Intervention type: PROCEDURE
Intervention: Biospecimen Collection
Description: Undergo collection of archived tissue and blood samples
Study NCT05530759 — intervention group
Intervention type: OTHER
Intervention: Medical Chart Review
Description: Review of medical record
Study NCT05925504 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Luspatercept
Description: The starting dose is 1.75mg/kg once every 3 weeks by subcutaneous injection. For rapid hemoglobin rise after 2 consecutive doses at the 1.75mg/kg starting dose, decrease the dose of Luspatercept or interrupt treatment. Otherwise, continue treatment with the dose of 1.75mg/kg once every 3 weeks.
Study NCT05507593 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DLL3-CAR-NK cells
Description: Patients of Group A will be received 1x10\^7 DLL3-CAR-NK cells infusion treatment，of group B will be received 1x10\^8 DLL3-CAR-NK cells infusion treatment，and of group C will be received 1x10\^9 DLL3-CAR-NK cells infusion treatment.
Study NCT06719323 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Walking Instruction with Support by Heart (Family WISH) program
Description: Researchers will compare the 12-week Family WISH program, based on self-efficacy theory, to a comparison group receiving a family walking health education sheet to evaluate the long-term effectiveness of the Family WISH program.
Study NCT06719323 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Comparison group
Description: a family walking health education sheet received
Study NCT06719310 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACC017+FTC/TAF
Description: ACC017+FTC/TAF
Study NCT06719310 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06714994 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: free spectacles
Description: Children will receive free spectacles
Study NCT06716086 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: shape memory alloy-based orthosis
Description: The home program with the shape memory alloy-based orthosis contains warm-up part and correction part. The SMA-based orthosis is an improvement over traditional dynamic splint. This corrective device uses shape memory alloy as an elastic component specifically designed to address finger joint stiffness. It provides continuous force for stiff joint in order to address stiffness.
Study NCT06716086 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional stretching program
Description: The home program for the stretching group includes active joint range of motion exercises and passive stretching exercises. Participants will follow instructions to perform various joint movements, with a focus on their restricted fingers.
Study NCT06718660 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tailored Educational Nursing program
Description: The intervention is a structured educational program designed to enhance nursing competence in biomedical waste management at El-Minia University Hospital. It was developed based on evidence-based guidelines, national and international standards, and a detailed assessment of baseline knowledge and practices among the participating nurses.
Study NCT06718946 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IDOV-SAFE
Description: Intravenous administration of oncolytic virus every 3 weeks until tumor progression
Study NCT06014216 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Flavoured ice lollies (popsicles)
Description: Blackcurrant flavoured ice popsicles, 105ml volume.
Study NCT06014216 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Water
Description: Water from tap, one cup given by recovery nurses.
Study NCT06715449 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 MG
Description: Participants allocated in the Intervention Group will be taking empagliflozin 10mg once a day in addition to their usual stroke care.
Study NCT06718153 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Immunohistochemistry and in situ hybridisation analysis
Description: immunohistochemistry and in situ hybridisation analysis for several markers, including p53, beta-Catenin and albumin, but also markers considered diagnostic for HCC such as Glutamin Synthetase, Glypican-3 and HSP70, to identify a more rational diagnostic-prognostic algorithm for primary liver lesions.
Study NCT06718959 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: the test product (Jet Floss EX)
Description: subjects continued to use distributed manual toothbrush and toothpaste every morning and evening, and add used the test product (Jet Floss EX) twice a day. Subjects used the test product (standard sprinkler, water twice) to flush all gingival margins and adjacent spaces with 440ml of water, start with water pressure gear 1 for the first time and continued with this gear after reaching the highest level that can be asapted. If felt uncomfortable, eligible subjects can adjust it to a suitable gear. The specific installation and usage of the teeth punch refer to the product instruction.
Study NCT06718959 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: the control product (interdental brush)
Description: subjects continued to use distributed manual toothbrush and toothpaste every morning and evening, and add auxiliary product (interdental brush) twice a day.
Study NCT05281913 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Psychoeducational Game
Description: Psychoeducational Game
Study NCT04624100 — intervention group
Intervention type: PROCEDURE
Intervention: Hernia repair
Description: Primary or mesh repair of primary ventral or incisional hernia
Study NCT06499727 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetazolamide
Description: Administration of 1x125mg acetazolamide in the morning, 1x125mg in the evening, starting 24 hours before departure to 3600 m.
Study NCT06499727 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administration of equally looking placebo capsules in the morning and in the evening, starting 24 hours before departure to 3600 m.
Study NCT06198075 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control Group
Description: Subjects will receive 6 weeks of general physical therapy,3 times/week for 30 min each session. The exercise program will include lying to sitting position, moving in the sitting posture, sitting and standing up, posture training for learning a normal gait pattern, weight bearing and weight movement training in the straight posture, walking training on the flat floor and stair walking. Final assessment will be done after 6 weeks